




























































Albumin（Alb）、 リ ン パ 球、Onodera’s prognostic 
nutritional index（PNI）、geriatric nutritional risk 
index（GNRI）、を比較した。PNIは小野寺らの算出
































５． 統 計 方 法 はX２ 検 定、Student t-testま た は
Mann-Whitney U-testをおのおの用いた。変数は平均
±標準偏差で表記し，P<0.05を統計学的有意差ありと







患 者 背 景 の 詳 細 をTable１ に 示 し た。ONS群 は






































Table 2 術後 3 か⽉⽬における測定値の⽐較 
 
 ONS 群 (n=11)  Control 群 (n=107) P value 
体重 (kg) 51.4 (±6.8) 50.6 (±8.6) 0.78 
Total protein (g/dl) 6.6 (±0.5) 6.6 (±0.5) 0.65 
Albumin (g/dl) 3.7 (±0.5) 3.7 (±0.4) §0.80  
Lymphocyte (/μl) 1920 (±981) 1735 (±644) 0.39 
PNI 46.9 (±7.9) 44.9 (±6.4) 0.32 
GNRI 94.5 (±7.7) 93.2 (±7.6) 0.59 
                                                    Student t-test (§ Mann-Whitney U-test) 
PNI: prognostic nutritional index, GNRI: geriatric nutritional risk index
Table 1  患者背景 
 
 ONS 群 (n=11) Control 群 (n=107) P value 
年齢 (range) 73.8 (57-83) 67.4 (37-80) 0.015 
性別（M/F） 5/6 62/45 0.43 
身長 (cm) 156.9 (±10.1) 158.3 (±8.7) 0.63 
体重 (㎏) 53.8 (±6.7) 56.0 (±9.1) 0.44 
Body mass index 21.9 (±2.1) 22.3 (±3.1) 0.63 
病理組織学的診断  
PDAC 3 36 0.44 
bile duct cancer 5 40  
IPMN 2 19  
NET 1 5  
others 0 7  
術前検査値    
Total protein (g/dl) 6.6 (±0.6) 6.3 (±1.1) 0.41 
Albumin (g/dl) 3.6 (±0.6) 3.6 (±1.1) 0.94 
Lymphocyte (/μl) 1658 (±875) 1594 (±543) 0.73 
PNI 44.8 (±7.9) 42.7 (±9.9) 0.48 
GNRI 94.8 (±7.9) 94.1 (±11.4) 0.85 
Student	t‐test	was	used	for	continuous	and	Chi‐square	test	for	categorical	variables 
PDAC: pancreatic ductal adenocarcinoma, IPMN: intraductal papillary mucinous neoplasm 
NET: neuroendocrine tumor, PNI: prognostic nutritional index,  
GNRI: geriatric nutritional risk index 
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Fig1 術前から術後 3 か⽉⽬にかけての変化率の⽐較 
















































































Fig.2 術後 1 週間⽬から術後 3 か⽉⽬にかけての変化率の⽐較 













































































































Fig. 3 術後 1 週間⽬の Alb3g/dl 以下の症例による術後 1 週間⽬から術後 3 か⽉⽬にかけての変
化率の⽐較 
 TP 変化率は ONS 投与群で有意に上昇していた。 
 
 















































































Mann-Whitney U-test was used for continuous and Chi-square test for categorical variables 
PNI: prognostic nutritional index, GNRI: geriatric nutritional risk index
 体重維持群 (n=53) 体重減少群 (n=39) P value 
性別（M/F） 31/22 21/18 0.65 
年齢 69.0 (±8.3) 66.3 (±9.5) 0.18 
術前体重 (kg) 55.2 (±9.7) 57.5 (±8.5) 0.23 
糖尿病合併 (n) 5 4 0.89 
術後合併症 (n) 5 6 0.38 
ONS 投与 (n) 10 1 0.01 
術前 Total protein (g/dl) 6.4 (±0.9) 6.4 (±1.1) 0.54 
術前 Albumin (g/dl) 3.7 (±0.7) 3.7 (±0.7) 0.63 
術前 Lymphocyte (/μl) 1532 (±606) 1710 (±522) 0.06 
術前 PNI 42.9 (±9.3) 44.7 (±9.8) 0.29 
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The effect of oral nutritional supplements for
pancreaticoduodenectomy
First Department of Surgery, Yamagata University Graduate School of Medical Science
Shuichiro Sugawara, Toshihiro Watanabe, Ryosuke Takahashi, Yuya Ashitomi,
Ryosuke Yamaga, Koji Tezuka, Ichiro Hirai, Wataru Kimura
Background: The present study aimed to clarify the effect of perioperative oral nutritional 
supplements（ONS）for pancreaticoduodenectomy（PD）on postoperative nutritional status.
Methods: 1．The ONS group included 12 patients who underwent PD at Yamagata University 
Hospital and received ONS（300kcal/250ml）once daily starting 1 week preoperatively and continuing 
until 3 months postoperatively. The control group included 107 patients who underwent PD at the 
same hospital and did not receive ONS.
　2．Total protein（TP）, Albumin（Alb）, lymphocytes, Onodera’s prognostic nutritional index
（PNI）, geriatric nutritional risk index（GNRI）, and weight were compared between the ONS and 
control groups at the 3rd postoperative month. In addition, change rates for TP, Alb, lymphocytes, 
PNI, and GNRI were compared. The change rate from the preoperative day to the 3rd postoperative 
month and the change rate from the 1st postoperative week to the 3rd postoperative month in the 
ONS and control groups were compared. Change rates from the 1st postoperative week to the 3rd 
postoperative month in patients with an Alb level < 3.0g/dl in the 1st postoperative week were also 
compared.
　3．Subjects with a weight change rate less than 10% were categorized in the weight maintenance 
group while subjects with a weight change rate more than 10% were categorized in the weight 
reduction group, and sex, age, preoperative weight, number of preoperative diabetic complications, 
number of postoperative complication events, amount of ONS administration, and preoperative TP, 
Alb, lymphocytes, PNI, and GNRI were compared.
Results: The change rate for weight from the preoperative day to the 3rd postoperative month 
improved significantly in the ONS group. Change rates of TP, lymphocytes, and PNI from the 1st 
postoperative week to the 3rd postoperative month improved significantly in the ONS group. The 
amount of ONS administration was significantly greater in the weight maintenance group. 
Conclusion: ONS administration for PD led to significant improvement in the weight reduction rate.
Key words: pancreaticoduodenectomy, oral nutritional supplements, nutritional indicators
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